Patent · US Expired

Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds

US7429616B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 15, 2005
Grant dateSep 30, 2008
Priority date
Expiry dateMar 22, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D309/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the synthesis and complete stereochemical assignments of cytotoxic compounds such as compound 28-a and its stereoisomers:The invention further provides processes for making the compounds, their synthetic intermediates, and for methods of using the compounds and their pharmaceutical compositions for the treatment of neoplastic diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.